Controlling endemic multidrug-resistant acinetobacter baumannii in intensive care units using antimicrobial stewardship and infection control

Korean Journal of Internal Medicine

Volumn 31, Issue 2, 2016, Pages 367-374

  Cheon, Shinhye ^a   Kim, Mi Ja ^b   Yun, Seon Jin ^c   Moon, Jae Young ^a   Kim, Yeon Sook ^a,c  

^a Chungnam National University   (South Korea)

^b Daejeon Development Institute   (South Korea)

^c Chungnam National University College of Medicine   (South Korea)

Author keywords

Acinetobacter baumannii; Antimicrobial stewardship; Infection control

Indexed keywords

ALCOHOL; AMPHOTERICIN; CARBAPENEM; CIPROFLOXACIN; COLISTIN; DORIPENEM; ECHINOCANDIN; ERTAPENEM; HYPOCHLORITE SODIUM; IMIPENEM; LINEZOLID; MEROPENEM; POLYPEPTIDE ANTIBIOTIC AGENT; POSACONAZOLE; TIGECYCLINE; VORICONAZOLE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIMICROBIAL STEWARDSHIP; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISINFECTION; DRUG USE; ENDEMIC SPECIES; ENVIRONMENTAL SANITATION; HAND WASHING; HOSPITAL INFECTION; HUMAN; INCIDENCE; INCIDENCE DENSITY RATE; INFECTION CONTROL; INTENSIVE CARE UNIT; MULTIDRUG RESISTANT ACINETOBACTER BAUMANNII; NONHUMAN; OUTCOME ASSESSMENT; PATIENT CARE; PROTECTIVE CLOTHING; TERTIARY CARE CENTER; ACINETOBACTER INFECTIONS; CHI SQUARE DISTRIBUTION; CROSS INFECTION; DRUG EFFECTS; ENDEMIC DISEASE; EVALUATION STUDY; HAND DISINFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; ODDS RATIO; PATHOGENICITY; PATIENT ISOLATION; PROCEDURES; PROGRAM EVALUATION; RISK FACTOR; SOUTH KOREA; TIME FACTOR; TRANSMISSION; TREATMENT OUTCOME;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CHI-SQUARE DISTRIBUTION; CROSS INFECTION; DISINFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENDEMIC DISEASES; HAND DISINFECTION; HUMANS; INCIDENCE; INFECTION CONTROL; MICROBIAL SENSITIVITY TESTS; ODDS RATIO; PATIENT ISOLATION; PROGRAM EVALUATION; REPUBLIC OF KOREA; RISK FACTORS; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84960126112     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2015.178     Document Type: Article

References (27)

1. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996;9:148-165.
2. Bergogne-Berezin E, Joly-Guillou ML, Vieu JF. Epidemiology of nosocomial infections due to Acinetobacter calcoaceticus. J Hosp Infect 1987;10:105-113.
3. Gaynes R, Edwards JR; National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005;41:848-854.
4. Paul M, Weinberger M, Siegman-Igra Y, et al. Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002. J Hosp Infect 2005;60:256-260.
5. Turton JF, Kaufmann ME, Warner M, et al. A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect 2004;58:170-179.
6. Coelho JM, Turton JF, Kaufmann ME, et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 2006;44:3623-3627.
7. Wendt C, Dietze B, Dietz E, Ruden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 1997;35:1394-1397.
8. Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008;8:751-762.
9. Kwak YG, Cho YK, Kim JY, et al. Korean nosocomial infections surveillance system, intensive care unit module report: data summary from July 2009 through June 2010. Korean J Nosocomial Infect Control 2011;16:1-12.
10. Das I, Lambert P, Hill D, Noy M, Bion J, Elliott T. Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect 2002;50:110-114.
11. Enoch DA, Summers C, Brown NM, et al. Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK. J Hosp Infect 2008;70:109-118.
12. Rodriguez-Bano J, Garcia L, Ramirez E, et al. Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive “bundle” approach. Am J Infect Control 2009;37:715-722.
13. La Forgia C, Franke J, Hacek DM, Thomson RB Jr, Robicsek A, Peterson LR. Management of a multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit using novel environmental disinfection: a 38-month report. Am J Infect Control 2010;38:259-263.
14. Munoz-Price LS, Carling P, Cleary T, et al. Control of a two-decade endemic situation with carbapenem-resistant Acinetobacter baumannii: electronic dissemination of a bundle of interventions. Am J Infect Control 2014;42:466-471.
15. Cohen AL, Calfee D, Fridkin SK, et al. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC position paper. Infect Control Hosp Epidemiol 2008;29:901-913.
16. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-332.
17. Maxwell M, Heaney D, Howie JG, Noble S. General practice fundholding: observations on prescribing patterns and costs using the defined daily dose method. BMJ 1993;307:1190-1194.
18. Lee SO, Kim NJ, Choi SH, et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 2004;48:224-228.
19. Lautenbach E, Synnestvedt M, Weiner MG, et al. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii. Infect Control Hosp Epidemiol 2009;30:1186-1192.
20. Su CH, Wang JT, Hsiung CA, et al. Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage. PLoS One 2012;7:e37788.
21. Ogutlu A, Guclu E, Karabay O, Utku AC, Tuna N, Yahyaoglu M. Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients. Ann Clin Microbiol Antimicrob 2014;13:7.
22. Lefebvre A, Gbaguidi-Haore H, Bertrand X, Thouverez M, Talon D. Impact of barrier precautions and antibiotic consumption on the incidence rate of acquired cases of infection or colonization with Acinetobacter baumannii: a 10-year multi-department study. Am J Infect Control 2011;39:891-894.
23. Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect 2007;65 Suppl 2:50-54.
24. Dancer SJ. The role of environmental cleaning in the control of hospital-acquired infection. J Hosp Infect 2009;73:378-385.
25. Hess AS, Shardell M, Johnson JK, et al. A randomized controlled trial of enhanced cleaning to reduce contamination of healthcare worker gowns and gloves with multidrug-resistant bacteria. Infect Control Hosp Epidemiol 2013;34:487-493.
26. Hayden MK, Bonten MJ, Blom DW, et al. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis 2006;42:1552-1560.
27. Eckstein BC, Adams DA, Eckstein EC, et al. Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. BMC Infect Dis 2007;7: 61.